I bought at 64 a couple of weeks ago. Doubled up at 54. (Documented here). Last 2 days was aggressive and sold half. Now back in again
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress